Structure-activity relationships of novel anti-malarial agents.: Part 4:: N-(3-benzoyl-4-tolylacetylaminophenyl)-3-(5-aryl-2-furyl)acrylic acid amides

被引:17
|
作者
Wiesner, J
Mitsch, A
Wissner, P
Krämer, O
Jomaa, H
Schlitzer, M
机构
[1] Univ Munich, Zentrum Pharmaforsch, Dept Pharm, D-81377 Munich, Germany
[2] Univ Klin Giessen, Inst Biochem, D-35249 Giessen, Germany
[3] Jomaa Pharmaka GmbH, D-35249 Giessen, Germany
[4] Univ Marburg, Inst Pharmazeut Chem, D-35032 Marburg, Germany
关键词
D O I
10.1016/S0960-894X(02)00555-3
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
In a previous report, we have described novel anti-malarial compounds based on a 2,5-diaminobenzophenone scaffold. Here, we have invesigated acryloyl derivatives carrying a biaryl structure consisting of a terminal aryl residue and a central 2-furyl ring. Several compounds were obtained in the series of para-substituted phenylfurylacryloyl derivatives that displayed improved anti-malarial activity in comparison to earlier described derivatives. From the structure-activity relationships it can be deduced that there has to be a lipophilic moiety in the para-position of the terminal phenyl residue. Furthermore, there are indications that, alternatively, activity may benefit from the presence of a polar moiety with hydrogen bond acceptor properties. (C) 2002 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:2681 / 2683
页数:3
相关论文
共 50 条
  • [1] Structure-activity relationships of novel anti-malarial agents.: Part 7:: N-(3-benzoyl-4-tolylacetylaminophenyl)-3-(5-aryl-2-uryl)acrylic acid amides with polar moieties
    Wiesner, J
    Mitsch, A
    Jomaa, H
    Schlitzer, M
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (13) : 2159 - 2161
  • [2] Structure-activity relationships of novel anti-malarial agents.: Part 6:: N-(4-arylpropionylamino-3-benzoylphenyl)-[5-(4-nitrophenyl)-2-furyl]acrylic acid amides
    Wiesner, J
    Fucik, K
    Kettler, K
    Sakowski, J
    Ortmann, R
    Jomaa, H
    Schlitzer, M
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (09) : 1539 - 1541
  • [3] Structure-activity relationships of novel anti-malarial agents.: Part 3:: N-(4-acylamino-3-benzoylphenyl)-4-propoxycinnamic acid amides
    Wiesner, J
    Kettler, K
    Jomaa, H
    Schlitzer, M
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2002, 12 (04) : 543 - 545
  • [4] Structure-activity relationships of novel anti-malarial agents:: Part 5.: N-(4-acylamino-3-benzoylphenyl)-[5-(4-nitrophenyl)-2-furyl]acrylic acid amides
    Wiesner, J
    Kettler, K
    Sakowski, J
    Ortmann, R
    Jomaa, H
    Schlitzer, M
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (03) : 361 - 363
  • [5] Structure-activity relationships of novel anti-malarial agents. Part 2: Cinnamic acid derivatives
    Wiesner, J
    Mitsch, A
    Wissner, P
    Jomaa, H
    Schlitzer, M
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2001, 11 (03) : 423 - 424
  • [6] Structure-Activity Relationships and Quantitative Structure-Activity Relationships Modeling of Some 3-(aryl)-N-(aryl)-1,2,4-Oxadiazol-5-Amine Derivatives as Anti-Proliferative Agents
    Belaidi, Salah
    Kerassa, Aicha
    Lanez, Touhami
    Cinar, Mehmet
    JOURNAL OF COMPUTATIONAL AND THEORETICAL NANOSCIENCE, 2015, 12 (09) : 2127 - 2133
  • [7] Non-thiol farnesyltransferase inhibitors:: N-(4-aminoacylamino-3-benzoylphenyl)-3-[5-(4-nitrophenyl)-2 furyl]acrylic acid amides and their antimalarial activity
    Kettler, K
    Wiesner, J
    Silber, K
    Haebel, P
    Ortmann, R
    Sattler, I
    Dahse, HM
    Jomaa, H
    Klebe, G
    Schlitzer, M
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2005, 40 (01) : 93 - 101
  • [8] Non-thiol farnesyltransferase inhibitors:: N-(4-acylamino-3-benzoylphenyl)-3-[5-(4-nitrophenyl)-2-furyl]acrylic acid amides
    Kettler, K
    Sakowski, J
    Silber, K
    Sattler, I
    Klebe, G
    Schlitzer, M
    BIOORGANIC & MEDICINAL CHEMISTRY, 2003, 11 (07) : 1521 - 1530
  • [9] Structure-activity relationships of novel anti-malarial agents: 1. arylacyl and cyclohexylacyl derivatives of 5-amino-2-tolylacetylaminobenzophenone
    Wiesner, J
    Mitsch, A
    Wissner, P
    Jomaa, H
    Schlitzer, M
    PHARMAZIE, 2001, 56 (06): : 443 - 444
  • [10] Antagonists of the human CCR5 receptor as anti-HIV-1 agents.: Part 2:: Structure-activity relationships for substituted 2-aryl-1-[N-(methyl)-N-(phenylsulfonyl) amino]-4-(piperidin-1-yl)butanes
    Finke, PE
    Meurer, LC
    Oates, B
    Mills, SG
    MacCoss, M
    Malkowitz, L
    Springer, MS
    Daugherty, BL
    Gould, SL
    DeMartino, JA
    Siciliano, SJ
    Carella, A
    Carver, G
    Holmes, K
    Danzeisen, R
    Hazuda, D
    Kessler, J
    Lineberger, J
    Miller, M
    Schleif, WA
    Emini, EA
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2001, 11 (02) : 265 - 270